{"ModuleTitle": "Company Description", "CompanyName": "Advaxis, Inc.", "Symbol": "ADXS", "Address": "305 COLLEGE ROAD EAST, PRINCETON,, New Jersey, 08540, United States of America", "Phone": "732 545 1590", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Advaxis is a clinical-stage biotechnology company focused on the development and\r\ncommercialization of proprietary Listeria monocytogenes, or Lm, Technology\r\nantigen delivery products based on a platform technology that utilizes live\r\nattenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These\r\nLm-based strains are believed to be a significant advancement in immunotherapy\r\nas they integrate multiple functions into a single immunotherapy and are\r\ndesigned to access and direct antigen presenting cells to stimulate anti-tumor T\r\ncell immunity, activate the immune system with the equivalent of multiple\r\nadjuvants, and simultaneously reduce tumor protection in the Tumor\r\nMicroenvironment, or TME, to enable T cells to eliminate tumors. The Company\r\nbelieves that Lm Technology immunotherapies can complement and address\r\nsignificant unmet needs in the current oncology treatment landscape.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2019%2f12%2f20%2f0001493152-19-019523.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andres A. GutiTrrez", "title": "Chief Medical Officer & Executive Vice President"}, {"name": "Kenneth A. Berlin", "title": "President, Chief Executive Officer & Director"}, {"name": "Michael Grace", "title": "Vice President-Technical Operations"}, {"name": "Molly Henderson", "title": "Chief Financial Officer & Executive Vice President"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}